Research Ties Diabetes Drug to Heart Woes
Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market.
The reports, obtained by The New York Times, say that if every diabetic now taking Avandia were instead given a similar pill named Actos, about 500 heart attacks and 300 cases of heart failure would be averted every month because Avandia can hurt the heart. Avandia, intended to treat Type 2 diabetes, is known as rosiglitazone and was linked to 304 deaths during the third quarter of 2009.
“Rosiglitazone should be removed from the market,” one report, by Dr. David Graham and Dr. Kate Gelperin of the Food and Drug Administration, concludes. Both authors recommended that Avandia be withdrawn.
U.S.: Controversial diabetes drug harms heart: Internal F.D.A. reports are part of fierce debate over Avandia
GSK to face FDA meeting over Avandia safety record
Au Revoir, Avandia? FDA Reviewers Urge Agency to Pull Drug: Doctors, Diabetes Experts Split on Whether Drug Should Be Eliminated
Health Buzz: FDA Report Advises Avandia Be Pulled From the Market